We are live on
!
Find out more
HI
HBK Investments Portfolio holdings
AUM
$10.3B
1-Year Est. Return
67.69%
This Fund
S&P 500
This Quarter
Est. Return
-0.27%
1 Year Est. Return
+67.69%
3 Year Est. Return
+191.59%
5 Year Est. Return
+445.48%
10 Year Est. Return
+2,540.16%
AUM
$15.2B
AUM Growth
+$771M
(+5.3%)
Cap. Flow
+$634M
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
51.67%
Holding
1,265
New
318
Increased
300
Reduced
316
Closed
276
Avg Time Held Equity + Options
2.6
quarters
Top 10 Avg Time Held Equity + Options
2.7
quarters
Top 20 Avg Time Held Equity + Options
2.7
quarters
Avg Time Held Equity only
2.6
quarters
Top 10 Avg Time Held Equity only
1.7
quarters
Top 20 Avg Time Held Equity only
1.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.29B |
| 2 |
XL
XL Group Ltd.
XL
|
+$167M |
| 3 |
CAVM
Cavium, Inc.
CAVM
|
+$93.7M |
| 4 |
AET
Aetna Inc
AET
|
+$73.5M |
| 5 |
Petrobras Class A
PBR.A
|
+$51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DST
DST Systems Inc.
DST
|
+$243M |
| 2 |
OA
Orbital ATK, Inc.
OA
|
+$217M |
| 3 |
AABA
Altaba Inc
AABA
|
+$130M |
| 4 |
HRG
HRG Group, Inc.
HRG
|
+$57.5M |
| 5 |
MDR
McDermott International
MDR
|
+$57.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.56% |
| 2 | Miscellaneous | 25.35% |
| 3 | Healthcare | 13.1% |
| 4 | Financials | 10.4% |
| 5 | Industrials | 10.09% |
Similar funds
GIM
LWCFA
DCP
BSL
NB
PCIA
MOACM
ECU
HBK Investments's Q2 2018 Portfolio in Review
As of Q2 2018, HBK Investments held 1,265 positions worth $15.2B, up 5.3% from $14.5B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
HBK Investments deployed $634M of net new capital in Q2 2018, opening 318 new positions and adding to 300 existing holdings. Its largest new stake was Celgene Corp: 15,550,600 shares worth $1.44B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $130M trimmed.
- HBK Investments's largest Q2 2018 buy was Celgene Corp: 15,550,600 shares worth $1.44B.
- HBK Investments added most to XL Group Ltd. in Q2 2018, an estimated $167M increase.
- HBK Investments's biggest Q2 2018 reduction was Altaba Inc, cutting an estimated $130M.
- HBK Investments fully exited DST Systems Inc. in Q2 2018, selling an estimated $243M.
- HBK Investments's ten largest holdings make up 52% of its $15.2B portfolio in Q2 2018.
- HBK Investments opened 318 new positions and closed 276 in Q2 2018.
- HBK Investments's portfolio value rose 5.3% quarter-over-quarter to $15.2B.
Based on HBK Investments's 13F filing for Q2 2018, filed 14 Aug 2018.